Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients

Autor: Caterina Finizia, Lisa Tuomi, Caroline Olsson, Johanna Hedström
Rok vydání: 2019
Předmět:
Larynx
AAA
Anisotropic Analytical Algorithm

Dose-volume histogram
HNC
head and neck cancer

BMI
body mass index

medicine.medical_treatment
R895-920
030218 nuclear medicine & medical imaging
Medical physics. Medical radiology. Nuclear medicine
0302 clinical medicine
3D-CRT
Three Dimensional Conformal Radiation Therapy

EQD2
equivalent dose in 2Gy fractions

Medicine
DVH
dose-volume histogram

Dysphagia-aspiration-related structures
MVA
multivariable logistic regression

RC254-282
N.A
non applicable

Cc
cubic centimeter

Radiation dose
OAR
organ-at-risk

PRO
patient-reported outcome

Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RT
radiation therapy

IMRT
intensity-modulated radiation therapy

Vx
the volume (%) of a structure receiving ≥xGy

Dysphagia
Deglutition disorders
ρ
Spearman’s Correlation Coefficient

CT
computed tomography

Parotid gland
Radiation therapy
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
PAS
penetration-aspiration scale

Radiology
PCM
pharyngeal constrictor muscle

medicine.symptom
Epiglottis
medicine.medical_specialty
EBRT
external beam radiation therapy

TNM
Tumor location
Nodular engagement
Metastasis

SEM
standard error of the mean

Head and neck neoplasms
Article
ACE-27
Adult Comorbidity Evaluation 27

AUC
area under the Receiver Operating Characteristic (ROC) curve

03 medical and health sciences
DESdC
Drinking
Eating
Swallowing difficulties and Coughing when eating/drinking

stomatognathic system
Swallowing
UVA
univariable logistic regression

otorhinolaryngologic diseases
Radiology
Nuclear Medicine and imaging

VFS
videofluoroscopy

ICRU
International Commission on Radiation Units and Measurements

Gy
Gray

business.industry
SLP
speech-language pathologist

Head and neck cancer
ROC
Receiver Operating Characteristic curve

medicine.disease
QoL
quality of life

CI
confidence interval

OR
odds ratio

UES
upper esophageal sphincter

SD
standard deviation

business
DARS
dysphagia-aspiration-related structures

VMAT
volumetric-modulated radiation therapy
Zdroj: Clinical and Translational Radiation Oncology, Vol 19, Iss, Pp 87-95 (2019)
Clinical and Translational Radiation Oncology
ISSN: 2405-6308
Popis: Highlights • Majority of DARS investigated for radiation-induced late dysphagia in HNC. • Epiglottis (E) and submandibular glands (SG) have previously not been reported as critical for dysphagia. • Reduced epiglottic inversion may explain the importance of E dose. • Interplay between xerostomia and dysphagia may explain the importance of SG dose. • Potential DVH thresholds to reduce dysphagia: E V60 = 60% and contralateral SG V60 = 17%
Background and purpose Dysphagia is a common, severe and dose-limiting toxicity after oncological treatment of head and neck cancer (HNC). This study aims to investigate relationships between radiation doses to structures involved in normal swallowing and patient-reported as well as clinically measured swallowing function in HNC patients after curative (chemo-) radiation therapy (RT) with focus on late effects. Materials and methods Patients (n = 90) with HNC curatively treated with RT ± chemotherapy in 2007–2015 were assessed for dysphagia post-treatment by telephone interview and videofluoroscopy (VFS). A study-specific symptom score was used to determine patient-reported dysphagia. The Penetration-Aspiration Scale (PAS) was applied to determine swallowing function by VFS (PAS ≥ 4/ ≥ 6 = moderate/severe dysphagia). Thirteen anatomical structures involved in normal swallowing were individually delineated on the patients’ original planning CT scans and associated dose-volume histograms (DVHs) retrieved. Relationships between structure doses and late toxicity were investigated through univariable and multivariable logistic regression analysis (UVA/MVA) accounting for effects by relevant clinical factors. Results Median assessment time was 7 months post-RT (range: 5–34 months). Mean dose to the contralateral parotid gland and supraglottic larynx as well as maximum dose to the contralateral anterior digastric muscle predicted patient-reported dysphagia (AUC = 0.64–0.67). Mean dose to the pharyngeal constrictor muscle, the larynx, the supraglottic larynx and the epiglottis, as well as maximum dose to the contralateral submandibular gland predicted moderate and severe dysphagia by VFS (AUC = 0.71–0.80). Conclusion The patients in this cohort were consecutively identified pre-treatment, and were structurally approached and assessed for dysphagia after treatment at a specific time point. In addition to established dysphagia organs-at-risk (OARs), our data suggest that epiglottic and submandibular gland doses are important for swallowing function post-RT. Keeping DVH thresholds below V60 = 60% and V60 = 17%, respectively, may increase chances to reduce occurrence of severe late dysphagia. The results need to be externally validated in future studies.
Databáze: OpenAIRE